WVE
Wave Life Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$4.86
+3.40%Margins
Gross margin
96.5%
EBITDA margin
-302.2%
EBIT margin
-333.4%
Net margin
-309.7%
FCF margin
-284.9%
-44.6%
Return on equity
-36.3%
Return on assets
-43.8%
Return on invested capital
0.11x
Asset turnover
-$184.7M
Cash from operations
$2.49
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026